Annual Drug Patent Expirations for BROVANA
Brovana is a drug marketed by Sunovion and is included in one NDA. It is available from two suppliers. There are eleven patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for BROVANA.
This drug has twenty-eight patent family members in thirteen countries.
The generic ingredient in BROVANA is arformoterol tartrate. Two suppliers are listed for this compound. Additional details are available on the arformoterol tartrate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
